Hi SanFran : You are considering a $100000 dollar purchase of Zenith, my vault won't allow for such a cashing however Zenith has Hugh potential in my mind , shared blood bank , thousands of epigenetic molecules for the treatment of cancer and autoimmune dieseases ,many more targets. Zenith is the royalty engine for not just Rvx-208 but all compounds within its fold, I think Zenith was a great idea allowing company to maneuver when creating regional deals and the likes . With an eight year head start in epignetics and most robust blood bank for targeting lead compounds Zenith is posed for its grand entrance and this private placement is a good faith measure to its Resverlogic loyal shareholders IMO... Retail investors are getting diluted ,yet if you where a long time investor in Rvx we still got them free ! Bring on Nasdaq !! And let's get recognized globally at least in the United States :) The stage is being set some will get more reward then others , nothing seems to change that way ... Stock